Blood Purification
Licensing agreement struck for Gradiflow technology
Published in Blood Weekly, October 31st, 2002
Under the agreement, Cangene will evaluate Gradipore's platform separation technology, Gradiflow, as an enhancement to its hyperimmune manufacturing process. During the first phase of the agreement, Gradipore will demonstrate that the Gradiflow technology can achieve strict levels of purity and recovery in an industrial setting on one of Cangene's products. The agreement specifies up-front and milestone payments by Cangene. Following the successful completion of the first phase, the companies...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2002-10-31)
More Articles from Blood Weekly
- Blood Products
EVA bags best for transporting frozen blood - Transfusion Medicine
Transfusion decliners usually have low mortality risk - Cardiac Surgery
Routine use of leukodepleted transfusion products offers little benefit - Stem Cell Transplantation
Fractionated TBI-based conditioning enables partially mismatched graft use - Stem Cell Transplantation
High-dose antibiotics can prevent etoposide-related infections - Transplant Medicine
'Killer' cells used to combat rare cancer - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
